Therapeutic Potentials of Centrally Acting Dopamine and α2-Adrenoreceptor Agonists
The antiparkinsonian activity of several dopamine agonists was investigated in an animal model and clinically in parkinsonian patients. The semisynthetic ergoline, pergolide, the partial ergoline, LY 141865 and the 8-α-aminoergoline, CU 32-085 were found to be effective antitremor agents in monkeys with ventromedial tegmental lesions. The administration of pergolide or LY 141865 results in a relief of tremor with a concomitant occurrence of severe abnormal involuntary movements, while the administration of CU 32-085 results in a relief of tremor with the occurrence of only minor abnormal involuntary movements. Clinical studies have revealed that pergolide is an effective drug in patients with advanced Parkinson’s disease, and it reduces the “on-off” phenomena. The possible regulation of dopamine neurotransmission by the norepinephrine neuronal systems was reviewed. Preliminary data suggest that clonidine may interact with presynaptic dopamine receptors.
Unable to display preview. Download preview PDF.
- Engel, J. A., Johannessen, K., Liljequist, S., Goldstein, M.: Enhancement of the haloperidol-induced suppression of food-reinforced lever-pressing behavior by interaction with a2-adrenoreceptors. Abstract, Society for Neuroscience, Minneapolis, Minn., 1982.Google Scholar
- Fuxe, K., Fredholm, B. B., Ogren, S.-O., Agnati, L. F., Hökfelt, T, Gustafsson, J. A.: Ergot drugs and central monoaminergic mechanisms: A histochemical, biochemical and behavioral analysis. Fed. Proc. 37, 2181–2191 (1978).Google Scholar
- Glaeser, B. S., Berry, J. C., Boyar, W. C., Lovell, R.A.: Effect of acute clonidine administration on striatal dopamine autoreceptors. Abstract, Society for Neuroscience, Minneapolis, Minn., 1982.Google Scholar
- Goldstein, M., Lew,J. Y., Sauter, A., Lieberman, A.: The affinities of ergot compounds for dopamine and dopamine antagonist receptor sites. In: Ergot Compounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects, pp. 75–82. New York: Raven Press. 1980.Google Scholar
- Rabey, J M., Passeltiner, P., Bystritsky, A., Engel, J., Goldstein, M.: The regulation of striatal DOPA synthesis by r2-adrenoreceptors. Brain Research 230, 422–426 (1981 a).Google Scholar
- Ungerstedt, U.: Stereotaxic mapping of the monoamine pathways in the rat brain. Acta physiol. Scand. Suppl. 367, 1–48 (1971).Google Scholar
- Walters,J. R., Roth, R. H.: Dopaminergic neurons: An in-vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg’s Arch. Pharmacol. 26, 5–12 (1976).Google Scholar